These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
849 related articles for article (PubMed ID: 19917699)
1. Tyrosine kinase 2 plays critical roles in the pathogenic CD4 T cell responses for the development of experimental autoimmune encephalomyelitis. Oyamada A; Ikebe H; Itsumi M; Saiwai H; Okada S; Shimoda K; Iwakura Y; Nakayama KI; Iwamoto Y; Yoshikai Y; Yamada H J Immunol; 2009 Dec; 183(11):7539-46. PubMed ID: 19917699 [TBL] [Abstract][Full Text] [Related]
2. IL-10 mediates resistance to adoptive transfer experimental autoimmune encephalomyelitis in MyD88(-/-) mice. Cohen SJ; Cohen IR; Nussbaum G J Immunol; 2010 Jan; 184(1):212-21. PubMed ID: 19949074 [TBL] [Abstract][Full Text] [Related]
3. Role of MOG-stimulated Th1 type "light up" (GFP+) CD4+ T cells for the development of experimental autoimmune encephalomyelitis (EAE). Yura M; Takahashi I; Serada M; Koshio T; Nakagami K; Yuki Y; Kiyono H J Autoimmun; 2001 Aug; 17(1):17-25. PubMed ID: 11488634 [TBL] [Abstract][Full Text] [Related]
4. Critical role of antigen-specific antibody in experimental autoimmune encephalomyelitis induced by recombinant myelin oligodendrocyte glycoprotein. Lyons JA; Ramsbottom MJ; Cross AH Eur J Immunol; 2002 Jul; 32(7):1905-13. PubMed ID: 12115610 [TBL] [Abstract][Full Text] [Related]
5. Infiltration of Th1 and Th17 cells and activation of microglia in the CNS during the course of experimental autoimmune encephalomyelitis. Murphy AC; Lalor SJ; Lynch MA; Mills KH Brain Behav Immun; 2010 May; 24(4):641-51. PubMed ID: 20138983 [TBL] [Abstract][Full Text] [Related]
6. Transglutaminase 2 exacerbates experimental autoimmune encephalomyelitis through positive regulation of encephalitogenic T cell differentiation and inflammation. Oh K; Park HB; Seo MW; Byoun OJ; Lee DS Clin Immunol; 2012 Nov; 145(2):122-32. PubMed ID: 23001131 [TBL] [Abstract][Full Text] [Related]
7. Plasmacytoid DC promote priming of autoimmune Th17 cells and EAE. Isaksson M; Ardesjö B; Rönnblom L; Kämpe O; Lassmann H; Eloranta ML; Lobell A Eur J Immunol; 2009 Oct; 39(10):2925-35. PubMed ID: 19637225 [TBL] [Abstract][Full Text] [Related]
9. Autoimmunity against myelin oligodendrocyte glycoprotein is dispensable for the initiation although essential for the progression of chronic encephalomyelitis in common marmosets. Jagessar SA; Smith PA; Blezer E; Delarasse C; Pham-Dinh D; Laman JD; Bauer J; Amor S; 't Hart B J Neuropathol Exp Neurol; 2008 Apr; 67(4):326-40. PubMed ID: 18379435 [TBL] [Abstract][Full Text] [Related]
10. CCR7 ligands are required for development of experimental autoimmune encephalomyelitis through generating IL-23-dependent Th17 cells. Kuwabara T; Ishikawa F; Yasuda T; Aritomi K; Nakano H; Tanaka Y; Okada Y; Lipp M; Kakiuchi T J Immunol; 2009 Aug; 183(4):2513-21. PubMed ID: 19625643 [TBL] [Abstract][Full Text] [Related]
11. T cell-depleted splenocytes from mice pre-immunized with neuroantigen in incomplete Freund's adjuvant involved in protection from experimental autoimmune encephalomyelitis. Zheng H; Zhang H; Liu F; Qi Y; Jiang H Immunol Lett; 2014; 157(1-2):38-44. PubMed ID: 24220208 [TBL] [Abstract][Full Text] [Related]
12. IL-6-deficient mice are resistant to experimental autoimmune encephalomyelitis: roles of IL-6 in the activation and differentiation of autoreactive T cells. Samoilova EB; Horton JL; Hilliard B; Liu TS; Chen Y J Immunol; 1998 Dec; 161(12):6480-6. PubMed ID: 9862671 [TBL] [Abstract][Full Text] [Related]
13. Mannan-conjugated myelin peptides prime non-pathogenic Th1 and Th17 cells and ameliorate experimental autoimmune encephalomyelitis. Tseveleki V; Tselios T; Kanistras I; Koutsoni O; Karamita M; Vamvakas SS; Apostolopoulos V; Dotsika E; Matsoukas J; Lassmann H; Probert L Exp Neurol; 2015 May; 267():254-67. PubMed ID: 25447934 [TBL] [Abstract][Full Text] [Related]
14. Invariant NKT cells producing IL-4 or IL-10, but not IFN-gamma, inhibit the Th1 response in experimental autoimmune encephalomyelitis, whereas none of these cells inhibits the Th17 response. Oh SJ; Chung DH J Immunol; 2011 Jun; 186(12):6815-21. PubMed ID: 21572032 [TBL] [Abstract][Full Text] [Related]
15. T-bet inhibits the in vivo differentiation of parasite-specific CD4+ Th17 cells in a T cell-intrinsic manner. Guo S; Cobb D; Smeltz RB J Immunol; 2009 May; 182(10):6179-86. PubMed ID: 19414771 [TBL] [Abstract][Full Text] [Related]
16. Reduced Treg frequency in LFA-1-deficient mice allows enhanced T effector differentiation and pathology in EAE. Gültner S; Kuhlmann T; Hesse A; Weber JP; Riemer C; Baier M; Hutloff A Eur J Immunol; 2010 Dec; 40(12):3403-12. PubMed ID: 21108463 [TBL] [Abstract][Full Text] [Related]
17. IL-7/IL-7 Receptor Signaling Differentially Affects Effector CD4+ T Cell Subsets Involved in Experimental Autoimmune Encephalomyelitis. Arbelaez CA; Glatigny S; Duhen R; Eberl G; Oukka M; Bettelli E J Immunol; 2015 Sep; 195(5):1974-83. PubMed ID: 26223651 [TBL] [Abstract][Full Text] [Related]
18. CXCR3 signaling in glial cells ameliorates experimental autoimmune encephalomyelitis by restraining the generation of a pro-Th17 cytokine milieu and reducing CNS-infiltrating Th17 cells. Chung CY; Liao F J Neuroinflammation; 2016 Apr; 13(1):76. PubMed ID: 27068264 [TBL] [Abstract][Full Text] [Related]
19. An MHC anchor-substituted analog of myelin oligodendrocyte glycoprotein 35-55 induces IFN-gamma and autoantibodies in the absence of experimental autoimmune encephalomyelitis and optic neuritis. Ford ML; Evavold BD Eur J Immunol; 2004 Feb; 34(2):388-97. PubMed ID: 14768043 [TBL] [Abstract][Full Text] [Related]
20. Inhibitory role of CD19 in the progression of experimental autoimmune encephalomyelitis by regulating cytokine response. Matsushita T; Fujimoto M; Hasegawa M; Komura K; Takehara K; Tedder TF; Sato S Am J Pathol; 2006 Mar; 168(3):812-21. PubMed ID: 16507897 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]